Back

Q&A, panel discussion and closing remarks

28 August 2026 (15:47 - 16:00)
Organised by: Logo
Congress Presentation Part of: ApoC‑III inhibition: entering a new era in managing risks of severe hypertriglyceridemia (sHTG) Lipids, Metabolism Open Access ESC Congress 2026 European Society of Cardiology

4 More presentations in this session

Presentation thumbnail
Welcome and agenda
Professor U. Laufs (Leipzig, DE)
Presentation thumbnail
Triglycerides: a cardiologists’ concern – what are the risks?
Professor U. Laufs (Leipzig, DE)
Presentation thumbnail
ApoC-III targeting: a new era in triglyceride management
Doctor S. Charriere (Bron, FR)
Presentation thumbnail
How I manage my patients with sHTG
Associate Professor T. Stulnig (Vienna, AT)

Access the full session

Session thumbnail
ApoC‑III inhibition: entering a new era in managing risks of severe hypertriglyceridemia (sHTG)

The Event

Event poster

ESC Congress 2026

28 August 2026 15:47 CET
You may be interested in
thumbnail
Congress Presentation
Questions & answers.
4 April 2022
thumbnail
Congress Session
What’s on the horizon in heart failure: precision medicine and tailored treatment
18 May 2025
thumbnail
Congress Presentation
Summary, panel discussion and Q&A
31 August 2025
thumbnail
Congress Presentation
Q&A and meeting close
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources